期刊文献+

β淀粉样蛋白PET显像剂^(11)C-DPOD的制备及其在动物体内的分布 被引量:2

Synthesis and Biological Evaluation of ^(11)C-DPOD for PET Imaging Agent of Amyloid-b in Mouse Brain
原文传递
导出
摘要 目的研究脑内β淀粉样蛋白(Aβ)的PET显像剂11C-DPOD即[N-甲基-11C]-3,5-二苯基-1,2,4-苯并噻唑的制备路线和在动物体内的分布情况。方法使用11C-三氟甲基磺酰甲烷(11C-triflate-CH3)和2 mg自制DPOD前体(溶于0.1 mL丁酮中,摇匀后装于3 mL的特制密闭反应瓶中,置-20℃)反应,在80℃水浴中对前体进行甲基化反应并完成11C标记。反应后的液体加入5 mL注射用水稀释,过活化的固相C18柱除去杂质,再用乙醇0.5 mL洗脱保留在柱上的产品。经无菌注射水稀释和0.22μm的微孔无菌滤膜过滤,得到澄清11C-DPOD乙醇水溶液。经尾静脉注射于转基因型阿尔茨海默病(AD)小鼠(AD小鼠)、正常C57老龄小鼠(正常老龄小鼠,作为对照);经肘静脉注射猕猴,进行动态显像。结果11C-DPOD注射液为无色澄清透明液体(pH 7.0),含10%的乙醇,放射性化学纯度>98%,产率为10%~15%。在AD小鼠和正常老龄小鼠体内显像差异无统计学意义;在猕猴体内11C-DPOD主要通过肝脏和胆囊代谢。结论11C-DPOD为合成的可以快速在转基因型痴呆小鼠和猕猴脑分布及清除的新型AβPET显像剂。 Aim To study the synthesis of ^11C-labeled PET amyloid-β (Aβ) imaging agent titled DPOD, a new series of ^11C-6-OH-BTA-1 derivatives, and biological evaluation of ^11C-DPOD for detecting amyloid-β plaques in mouse brain. Methods ^11C-triflate-CH3 was bubbled into 2 mg precursor DPOD, which was dissolved in 0.1 mg methyl ethyl ketone, to generate HC-DPOD in a V-tube at high temperature (about 80 ℃). The radiolabelled products were purified by HPLC. Then the image of radioactive concentration of transgenic,senile mice and rhesus monkey was made by using PET/CT. All data were analyzed by Stata 10.0 software (P〈0.05). Results ^11C-DPOD was a kind of colorless transparent liquid with ethyl alcohol about 10%, pH7.0. The radiochemical purity was over 95% and the average radiolabeling yield was from 10% to 15%.^11C-DPOD had the same effect as ^11C-PIB in pharmacokinetics of transgenic and senile mice. Conclusion ^11C-DPOD radioactivity of brain was synthesized by ourselves and washed out quickly thereafter in both transgenic mice and monkey.
出处 《中国临床神经科学》 2013年第1期12-18,共7页 Chinese Journal of Clinical Neurosciences
关键词 Β淀粉样蛋白 显像剂 [N-甲基-^11C]-3 5-二苯基-1 2 4-苯并噻唑 PET CT 药动学 阿尔茨海默病 小鼠 猕猴 amyloid-β imaging agent [N-methyl-^11C]-3,5-diphenyl-1,2,4-oxadiazole PET/CT pharmacokinetics Alzheimer's disease mouse rhesus monkey
  • 相关文献

参考文献18

  • 1Glenner GG,Wong CW. Alzheimer's disease:initial report of the purification and characterization of a novel cerebrovascular amyloid protein[J].Biochemical and Biophysical Research Communications,1984.885-900.
  • 2孔繁军,韩晓涛,张茁.β-淀粉样蛋白与阿尔茨海默病神经元退变的研究现状[J].神经疾病与精神卫生,2007,7(6):459-460. 被引量:13
  • 3Bormans GM,Van Oosterwyck G,Groot TJ. Synthesis and biologic evaluation of (11)c-methyl-d-glucoside,a tracer of the sodium-dependent glucose transporters[J].The Journal of Nuclear Medicine,2003.1075-1081.
  • 4Klunk WE,Engler H,Nordberg A. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B[J].Annals of Neurology,2004,(3):306-319.doi:10.1002/ana.20009.
  • 5Klunk WE,Lopresti BJ,Ikonomovic MD. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain[J].Journal of Neuroscience,2005.10598-10606.
  • 6Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease.FDG-PET studies in MCI and AD[J].European Journal of Nuclear Medicine and Molecular Imaging,2005,(4):486-510.doi:10.1007/s00259-005-1762-7.
  • 7Shin J,Lee SY,Kim SJ. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers:PIB,FDDNP,and FDG[J].Neuroimage,2010.488-496.
  • 8Hong MC,Kim YK,Choi JY. Synthesis and evaluation of stilbene derivatives as a potential imaging agent of amyloid plaques[J].Bioorganic and Medicinal Chemistry Letters,2010.7724-7730.
  • 9Zhang W,Oya S,Kung MP. F-18 stilbenes as PET imaging agents for detecting β-amyloid plaques in the brain[J].Journal of Medicinal Chemistry,2005.5980-5988.
  • 10Zhang W,Kung MP,Oya S. 18F-labeled styrylpyridines as PET agents for amyloid plaque imaging[J].Nuclear Medicine and Biology,2007.89-97.

二级参考文献2

共引文献15

同被引文献8

  • 1Jobst KA,Barnetson LP,Shepstone BJ. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia:the use of NINCDS-ADRDA and DSM-Ⅲ-R criteria,SPECT,X-ray CT,and Apo E4 in medial temporal lobe dementias.Oxford Project to Investigate Memory and Aging[J].International Journal of Geriatric Psychiatry,1998.271-302.
  • 2Mayeux R,Saunders AM,Shea S. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer' s disease.Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease[J].New England Journal of Medicine,1998.506-511.
  • 3Ranginwala NA,Hynan LS,Weiner MF. Clinical criteria for the diagnosis of Alzheimer disease:still good after all these years[J].American Journal of Geriatric Psychiatry,2008.384-388.
  • 4Wong DF,Rosenberg PB,Zhou Y. In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45(florbetapir[corrected]F 18)[J].The Journal of Nuclear Medicine,2010.913-920.
  • 5Clark CM,Schneider JA,Bedell BJ. Use of florbetapir-PET for imaging beta-amyloid pathology[J].Journal of the American Medical Association,2011.275-283.
  • 6姚志文,丁正同,王坚,蒋雨平,管一晖.β淀粉样蛋白显像剂[^(11)C]6-OH-BTA-1在转基因型痴呆鼠和正常猴体内的分布[J].中国临床神经科学,2009,17(4):365-370. 被引量:4
  • 7毛洁萍,丁正同,杨新玲,蒋雨平.阿尔茨海默病脑β淀粉样蛋白的PET显像[J].中国临床神经科学,2009,17(6):636-642. 被引量:5
  • 8贾星星,刘剑刚,李浩.Tau蛋白及异常磷酸化在阿尔茨海默病中的研究进展[J].中国临床神经科学,2015,23(5):591-596. 被引量:8

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部